QTMeds

Drug Database Monograph

ELREXFIO 40 mg/mL

PENDING REVIEW

Active Ingredient: ELRANATAMAB

QTc Interval Status:

neutral

Clinical Description (Database Summary)

Scientific Sources / References

Analyse RCP (Automatique), id : 65312065

← Back to Prescription Analyzer